<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01555060</url>
  </required_header>
  <id_info>
    <org_study_id>714</org_study_id>
    <nct_id>NCT01555060</nct_id>
  </id_info>
  <brief_title>Hemoglobin and Iron Recovery Study</brief_title>
  <acronym>HEIRS</acronym>
  <official_title>Hemoglobin and Iron Recovery Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institute for Transfusion Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Blood Center of Wisconsin</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Blood Centers of the Pacific</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>American National Red Cross</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Blood Systems Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>RTI International</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>National Heart, Lung, and Blood Institute (NHLBI)</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the effect of daily iron supplements after blood
      donation on time to recovery of hemoglobin and iron stores. The study will also determine
      whether the effect of iron supplements on time to recovery is different in men and women, in
      older vs. younger donors (&lt;60 years old vs. at least 60 years old) and in donors with replete
      vs. diminished pre-donation iron stores.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The effect of taking iron supplements after blood donation on time to recovery of hemoglobin
      has been documented but it is not clear whether the benefits of iron supplements vary with
      age, gender or iron stores. To study this issue, individuals who are eligible to donate
      blood, based on hemoglobin level, will be randomized to receive daily iron supplements or no
      supplements. Randomization will be stratified on gender (male or female), age (&lt;60 years old
      vs. at least 60 years old) and iron status (serum ferritin &gt;26 vs serum ferritin no greater
      than 26). Subjects will be followed for 24 weeks with periodic blood draws to determine time
      to recovery of hemoglobin and iron stores. A 7 ml (about 1.5 teaspoons) blood sample will be
      drawn at each of seven study visits over the 24 weeks to track recovery of hemoglobin and
      iron.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Actual">June 2013</completion_date>
  <primary_completion_date type="Actual">May 2013</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to recovery of hemoglobin after blood donation</measure>
    <time_frame>Up to 24 weeks after blood donation</time_frame>
    <description>Hemoglobin will be measured 3-7 days and 2, 4, 8, 12, 16 and 24 weeks after blood donation. A nonlinear regression of hemoglobin vs time since donation will be used to determine time to recovery of hemoglobin to 80% of the pre-donation level.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Iron stores</measure>
    <time_frame>Up to 24 weeks after blood donation</time_frame>
    <description>Ferritin will be measured 3-7 days and 2, 4, 8, 12, 16 and 24 weeks after blood donation. A nonlinear regression of hemoglobin vs time since donation will be used to determine time to recovery of to pre-donation iron stores.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total body iron</measure>
    <time_frame>24 weeks after blood donation</time_frame>
    <description>Soluble transferrin receptor (sTfR) in blood will be measured 3-7 days and 24 weeks after blood donation. The ratio of sTfR to ferritin will provide a measure of total body iron at the two time points. Recovery of total body iron will be estimated from the difference between the ratios at the two time points.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">215</enrollment>
  <condition>Recovery of Hemoglobin and Iron Stores After Blood Donation</condition>
  <arm_group>
    <arm_group_label>Iron supplements</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects who are randomized to receive daily iron supplements after donating blood</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Subjects who are randomized not to receive daily iron supplements after donating blood</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>ferrous gluconate</intervention_name>
    <description>daily capsule of ferrous gluconate containing 38 mg of elemental iron</description>
    <arm_group_label>Iron supplements</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  potential blood donors with hemoglobin of at least 12.5 gm/dL

          -  no blood donation for at least 4 months

          -  successful donation of a unit of whole blood

        Exclusion Criteria:

          -  individuals who are taking iron supplements including multivitamins containing iron
             and refuse to stop do so for the 24 weeks of the study.

          -  baseline ferritin &gt;300 ug/L (to exclude individuals with hemochromatosis)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joe Kiss, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute for Transfusion Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Blood Centers of the Pacific</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94118</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>American Red Cross, Connecticut Region</name>
      <address>
        <city>Farmington</city>
        <state>Connecticut</state>
        <zip>06032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institute for Transfusion Medicine</name>
      <address>
        <city>PIttsburg</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Blood Center of Wisconsin</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 9, 2012</study_first_submitted>
  <study_first_submitted_qc>March 13, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 15, 2012</study_first_posted>
  <last_update_submitted>January 22, 2014</last_update_submitted>
  <last_update_submitted_qc>January 22, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 23, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>hemoglobin recovery</keyword>
  <keyword>iron recovery</keyword>
  <keyword>iron supplements</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Iron</mesh_term>
    <mesh_term>Ferrous gluconate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

